Objective: To better understand the reasons for decreased survival rates in elderly patients with rectal cancer by performing an epidemiologic evaluation of age-related differences in treatment and survival. Summary Background Data: The incidence of rectal cancer increases with older age, and localized disease can be curatively treated with stage-appropriate radical surgery. However, older patients have been noted to experience decreased survival. Methods: Patients with localized rectal adenocarcinoma were identified in the Surveillance, Epidemiology, and End Results database (1991)(1992)(1993)(1994)(1995)(1996)(1997)(1998)(1999)(2000)(2001)(2002). Cancer-specific survival by age, sex, surgery type, tumor grade, lymph node status, and use of radiation therapy was evaluated using univariate and multivariate regression analysis. Results: We identified 21,390 patients who met the selection criteria. The median age was 68 years. Each half-decade increase in age Ն70 years was associated with a 37% increase in the relative risk (RR) for cancer-related mortality (RR ϭ 1.37; 95% confidence interval ͓CI͔, 1.33-1.42); decreased receipt of cancer-directed surgery (odds ratio ͓OR͔ ϭ 0.56; 95% CI, 0.36 -0.63); more local excision and less radical surgery (OR ϭ 0.76; 95% CI, 0.72-0.81); less radiotherapy (OR ϭ 0.64; 95% CI, 0.61-0.67); and greater likelihood of N0 pathologic stage classification (OR ϭ 1.10; 95% CI, 1.05-1.15) (P Ͻ 0.0001 for each factor). The effect of age on cancer-specific mortality persisted in multivariate analysis with each half-decade increase in age Ն70 years resulting in a 31% increase in cancer-specific mortality (RR ϭ 1.31; 95% CI, 1.25-1.36; P Ͻ 0.0001). Conclusions: In elderly patients, rectal cancer is characterized by decreased cancer-related survival rates that are associated with less aggressive treatment overall and decreased disease stages at presentation. Investigation into the reasons for these treatment differences may help to define interventions to improve cancer outcomes. (Ann Surg 2007;246: 215-221) A pproximately 41,000 new cases and about 15,000 deaths due to rectal cancer were reported in the United States in 2005, and the incidence increases with increasing age.
A pproximately 41,000 new cases and about 15,000 deaths due to rectal cancer were reported in the United States in 2005, and the incidence increases with increasing age. 1 Unfortunately, a disproportionately poor survival after colorectal cancer diagnosis in elderly patients has been reported. [2] [3] [4] [5] There are many reasons for the poor survival in these patients, ranging from less aggressive screening strategies to decreased adherence to accepted surgical and adjuvant treatment guidelines for rectal cancer. 4, 6, 7 These factors are becoming increasingly important as the population in the United States continues to age; in 2003, the average life expectancy at 70 years of age was 14.9 years, and that at 80 years of age was 9.0 years.
The primary method of curative treatment of localized rectal cancer remains surgical resection. Surgical options include transanal excision and radical surgery. In all but the earliest stages of rectal cancer (T1N0) without adverse histologic features, curative treatment is radical surgery consisting of surgical removal of the affected rectum along with its associated lymphatic drainage. When compared with radical surgery, use of local excision results in higher local failure rates and decreased survival rates as the procedures carry the risk of leaving unresected viable tumor cells within the draining lymph nodes. 8 Furthermore, a full evaluation of the nodal basin for definitive staging of and further treatment planning for rectal cancer can only be performed after adequate radical surgery. Therefore, the proper selection of the appropriate surgical treatment of rectal cancer is essential both for therapy and for prognosis.
The data on the types of surgical therapy for rectal cancer used in elderly patients are limited. As clear relationships exist between the use of stage-appropriate surgical treatment and survival for rectal cancer, it is important to investigate the relationship between the type of surgical therapy for rectal cancer and age. 8 Therefore, we performed an epidemiologic evaluation of age-related differences in rectal cancer treatment and survival using Surveillance Epidemiology and End Results (SEER) data to characterize the treatment factors that influence outcome of this disease in elderly patients. We hypothesized that increasing age among patients with rectal cancer was associated with decreasing cancer-specific survival and that this difference is related to a decrease in the use of radical surgery.
METHODS

Data Source and Case Identification
A cohort study of all cases of localized rectal cancer collected in the SEER registry from 1991 to 2002 was performed. SEER is a National Cancer Institute program that obtains and publishes cancer incidence and survival data from population-based cancer registries for approximately 26% of the U.S. population; specifically, the program collects data on patient demographics, primary tumor site, tumor morphology and stage at diagnosis, first course of treatment, and vital status. 9 The time span of 1991 to 2002 was chosen to evaluate the outcomes of rectal cancer treatment since the publication of the National Institutes of Health Consensus Conference Guidelines for adjuvant therapy for colorectal cancer in 1990. 10 All patients with adenocarcinoma of the rectum (excluding rectosigmoid) without distant metastases were identified. Patients in whom the diagnosis of rectal cancer was not their only cancer diagnosis were excluded. This left a total of 21,390 patients with locoregional rectal adenocarcinoma. Baseline patient demographics, including age at diagnosis, sex, race/ethnicity, and year of diagnosis, were evaluated. Because this study used preexisting data with no personal identifiers, it was exempt from review by our institutional review board.
Cancer-related Data
The cancer-related data evaluated for each patient consisted of identification of the use and the type of surgery (eg, local excision versus radical resection) performed using the SEER variables "site-specific surgery" codes for cases prior to 1998 and "surgery of primary site" codes for cases starting in 1998 (Table 1) ; use of radiation; tumor grade (welldifferentiated, moderately differentiated, poorly differentiated, or undifferentiated or anaplastic); and tumor stage using the SEER-modified American Joint Committee on Cancer staging system. 11 Patients were considered to have undergone cancer-directed surgery according to the SEER definition (ie, if local excision or radical resection was performed and a specimen was available for pathologic review). The SEER registry also codes cause of death; therefore, cancer-specific survival was analyzed. Cases were censored if death was due to a cause other than rectal cancer or the patient was alive at follow-up.
Survival and Statistical Analysis
Because colorectal cancers in patients under 50 years of age are more likely to be associated with genetic predisposition, have a delay in diagnosis, and not be identified by conventional screening, we evaluated actuarial cancer-specific survival rates using Cox regression analysis among patients 50 years of age or older. This group consisted of 18,890 patients, or 88.3% of the total group. Patients were categorized into half-decade age groups, which were used as a continuous predictor variable to determine the relative risk for each half-decade change in age. Patients were then grouped to those between 50 to 69 years of age and those Ն70 years of age for further survival and treatment analysis. Univariate analysis was performed to evaluate the effect of sex, race/ethnicity, tumor grade, tumor stage (stage I or II vs. Multivariate Cox proportional hazards regression was performed to evaluate risk-adjusted outcomes, predicting the risk of dying of rectal cancer. For the multivariate analyses, the independent covariates included those identified by the univariate comparisons of survival. In addition, the Cox proportional hazards model was evaluated for interactions between the predictor variables. Age-related differences in the types of surgery performed and tumor related variables were evaluated using logistic and linear regression models for categorical and continuous predictor variables, respectively. The proportions of patients receiving different surgical interventions and having different pathologic tumor stages were compared using logistic regression analysis and the 2 test. Furthermore, the data were evaluated for interactions between age and tumor stage, age and use of any cancerdirected surgery, age and the use radical surgery when cancer-directed surgery was performed, age and use of radiation therapy, age and tumor stage, and age and tumor grade.
Statistical analyses were performed using the Number Cruncher Statistical Software program (version 2004, Number Cruncher Statistical Analysis System, Kaysville, UT). P values less than 0.05 were considered statistically significant.
RESULTS
The baseline characteristics of the study patients are listed in Table 2 . Of the 21,390 patients with rectal cancer who met the study inclusion criteria, the mean age was 66.5 years and median age was 68 years with an interquartile range of 57 to 77 years. Overall, more patients were male (57.1%) and most patients were white (82.0%, including Hispanic). Most tumors were moderately differentiated (66.4%) and localized without apparent regional lymph node involvement (64.8%). The type of surgery performed could be evaluated in all but 128 (0.6%) of the patients.
We could identify the cause of death in all but 389 (5%) of the patients who died during follow-up (n ϭ 8364). Of those patients who died, 61.5% had deaths recorded as being due to their cancer. The overall 5-year survival rates were 70.8%, 54.3%, and 45.5% in patients with stage I, II, and III disease, respectively. The cancer-specific survival rates were better (85.8%, 67.8%, and 54.1% in patients with stage I, II, and III disease, respectively).
We next evaluated age (half-decade increments) as a univariate predictor of cancer-specific survival using Cox regression. Older patients had lower cancer-specific survival rates than younger patients did (HR death 1.12; 95% confidence interval ͓CI͔, 1.11-1.14, P Ͻ 0.0001) and this association between cancer-specific survival and age was markedly more pronounced in patients Ն70-year-old (HR death 1.37; 95% CI, 1.33-1.42, P Ͻ 0.0001). We also evaluated other patientrelated predictors of survival, including sex and race/ethnicity. The patients' sex did not affect cancer-specific survival (P ϭ 0.40); however, black patients were more likely to die of their cancer than were white patients (risk ratio ͓RR͔ ϭ 1.50; 95% CI, 1.34 -1.69, P Ͻ 0.0001), whereas Asian patients were less likely to die of their cancer than white patients were (RR ϭ 0.87; 95% CI, 0.79 -0.95, P ϭ 0.005) ( Table 3) .
Tumor factors, including tumor grade (P Ͻ 0.0001) and stage (P Ͻ 0.0001), were significantly associated with cancer-specific survival. Because the tumor stage at diagnosis may determine the type of surgery performed as well as the use of radiation therapy, we evaluated these variables after stratifying the patients by stage. We compared survival rates after radical surgery versus local excision in patients with each tumor stage at diagnosis. There was no significant difference in outcome in patients with stage I tumors who underwent local excision or radical surgery (P ϭ 0.17), but there was a significant improvement in outcome in patients with stage II disease after radical surgery when compared with local excision (P Ͻ 0.0001). We also identified an association between the use of adjuvant radiation therapy and poorer outcomes in patients with stage I disease (P Ͻ 0.0001) 
Annals of Surgery
Rectal Cancer in the Elderly and better survival outcomes in patients with stage III disease (P Ͻ 0.0001) ( Table 3) . We also performed Cox multivariate regression analysis to adjust for potential confounder effects of the univariate predictor variables. The use of radical surgery or radiation did not have consistent effects on outcomes across all stages (eg, radiation associated with increased risk for death for stage I and improved risk for stage III), in part related to lack of stage appropriate utilization; therefore, these terms were excluded from multivariate analysis. Sex was clinically expected to potentially influence age-related life expectancy; therefore, it was included in the multivariate analysis despite the univariate findings. Univariate analysis of age demonstrated that the greatest age-related effects on cancer-specific survival occurred in the patients who were Ն70 years of age (per half-decade: RR ϭ 1.04; 95% CI, 1.0 -1.09, P ϭ 0.07 for patients 50 -69 years of age vs. RR ϭ 1.37; 95% CI, 1.33-1.42, P Ͻ 0.0001 for patients Ն70 years of age). Therefore, we performed separate multivariate regression analysis in the 2 cohorts. The results of these analyses are shown in Table 4 .
Among patients who underwent cancer-directed surgery, increasing age was significantly associated with an increased likelihood of dying from rectal cancer even after adjustment for sex, race/ethnicity, grade, and stage (RR ϭ 1.31; 95% CI, 1.25-1.36, P Ͻ 0.0001).
We then sought to identify the reasons for the agerelated decrease in cancer-specific survival rates. Table 5 lists the odds ratios associated with each half-decade increase in age for each of the variables listed. The odds of undergoing any cancer directed surgery decreased by 44% (OR ϭ 0.56; 95% CI, 0.36 -0.63, P Ͻ 0.0001) for each 5-year incremental increase in age Ն70 years. When cancer directed surgery was performed, each 5-year incremental increase in age over Ն70 years was associated with a 24% reduction in the odds of undergoing radical surgery (OR ϭ 0.76; 95% CI, 0.72-0.81, P Ͻ 0.0001) ( Table 5 ). As age increased, patients were significantly more likely to be staged with lymph node negative disease than lymph node-positive disease (P ϭ 0.0001), but no significant difference existed for classification within one of the 2 node-negative stages (ie, stage I vs. stage II) (P ϭ 0.51) or for histologic grade (P ϭ 0.25-0.90). As age increased, patients were also less likely to receive adjuvant radiation therapy and more likely to undergo local excision rather than radical surgery. We determined if age was associated with an increased use in radiation therapy among those patients undergoing local excision. Despite an increased use of local excision, older patients undergoing local excision were still less likely to receive radiation therapy (OR ϭ 0.90; 95% CI, 0.87-0.94, P Ͻ 0.0001, age 50 -69 years), and this effect was more pronounced among patients Ͼ69 years of age (OR ϭ 0.64; 95% CI, 0.61-0.67, P Ͻ 0.0001).
We then evaluated the association between cancerspecific survival and age for each tumor stage and each surgery type (local excision or radical surgery). The effect of increasing age on survival after cancer-directed surgery was greater in patients with stage I disease when compared with other stages (Table 6) . Also, the effect of increasing age was greater in patients who underwent local excision than in those who underwent radical surgery.
DISCUSSION
Our examination of the SEER registry data demonstrated that the rectal cancer-specific survival rates decreased as patient age increased. We also found a decreased use of any cancer directed treatment, an increased use of local excision, a decreased use of radical surgery, and a decreased stage at presentation as the patients' age increased. The latter observation is likely to have been a result of understaging because of surgical undertreatment, as accurate stage assignment may not be possible with local excision.
Cancer-directed and stage-appropriate surgical resection for localized rectal cancer is essential for optimal survival outcomes. The oncologically appropriate treatment, therefore, is local excision for T1 lesions without adverse prognostic features or evidence of lymph node metastasis and radical en bloc resection of the rectum and mesorectum for all other lesions. 8, 12 Local excision with neoadjuvant chemora- diotherapy for T2N0 lesions is currently being investigated in an ongoing American College of Surgeons Oncology Group multicentered clinical trial as local excision alone in this setting has been associated with increased risk for local failure and decreased long-term survival rates. 13, 14 Our findings provide further insight beyond prior reports of decreased overall survival among elderly patients with colorectal cancer. 2, 4, 5 Multiple factors have been proposed to contribute to this decrease in survival including treatment utilization and patient factors. A potential confounding factor is that older patients are more likely to die of causes other than their cancer resulting in an apparent decrease in the overall survival. We therefore evaluated cancer-related survival. In the SEER dataset, misclassification of the cause of death is possible, but our method of censoring cases by cause of death would have resulted in a bias toward underestimation of the effect of age on cancer-related deaths in our analysis.
To determine the potential contribution of the type of surgical therapy to decreased survival rates among the elderly patients with rectal cancer, we first examined the use of any cancer-directed surgery and identified a significantly decreased use of cancer-directed surgery among the elderly. In this study, elderly patients were less likely to undergo any cancer-directed surgery and with each one-half-decade increase in age Ն70 years, the odds for receiving cancerdirected surgery was reduced by 44%. Whereas a previous study of the SEER registry found that only patients above the age of 80 years were less likely to undergo cancer-directed surgery for rectal cancer, we demonstrated a larger effect of age that may have been related to our more stringent study inclusion criteria. 15 To control for the survival effect of the lack of rectal cancer-directed surgery, we evaluated the effect of age on the type of surgery performed in patients who underwent cancerdirected surgery. We identified a significant association between increasing age and both decreasing use of radical surgery and increasing use of local excision. We also found that increasing age was associated with decreasing likelihood of node-positive rectal cancer stage (stage III vs. stage I or II) but was not associated with a change in T stage at presentation (stage I vs. stage II). We also did not find an association between tumor grade at presentation and age.
Taken together, these data suggest that increasing age with rectal cancer is associated with an increasing likelihood for surgical undertreatment with local excision rather than radical surgery, where few if any lymph nodes are evaluated and therefore resulting in pathologic understaging. A previous analysis of aggregated data obtained from the surgical literature demonstrated higher stages of rectal cancer at presentation in elderly patients when compared with younger patients, 2 a finding that suggests a selection bias in the reported surgical series but nonetheless argues that our findings regarding stage at diagnosis are related to the treatment rather than the disease. These factors may lead to differences in the use of subsequent postsurgical treatment such as adjuvant chemotherapy, further resulting in impaired survival outcomes.
To determine whether patients with rectal cancer were more likely to undergo a combined approach of radiation therapy and local excision to avoid radical surgery as they aged, we evaluated the associations between age, tumor stage, and use of adjuvant radiation therapy. At each stage, patients were less likely to receive adjuvant radiation as they aged. Moreover, increased use of local excision among the elderly patients was not associated with increased use of radiation therapy; indeed, older patients who underwent local excision were less likely to undergo adjuvant radiation therapy for rectal cancer than younger patients were. These findings are consistent with the results of prior studies of data obtained from population-based registries in several other countries.
7,16 However, we found that patients who underwent local excision and adjuvant radiation therapy had poorer survival when compared with patients who underwent local excision without radiation therapy, suggesting that radiation therapy may have been used as a substitute for radical surgery in a subset of patients who underwent local excision.
This study is subject to limitations inherent to the dataset. The SEER registry does not collect comorbidity data. One reason that the elderly patients may be undergoing less cancer-directed surgery may be that surgery may be contraindicated due to comorbidities or that a patient chose to undergo local excision when radical surgery may have been indicated. Unfortunately, in this analysis, it is not possible to determine why a patient underwent local excision or radical resection and this is an important unanswered question. However, by using cancer-specific survival data censoring for non-cancer-related causes of death, we have made an effort to minimize the impact of this limitation. Despite the influence of comorbidity, age has been demonstrated to be an independent predictor of receipt of treatment. Within the Ontario Cancer Registry, breast and colorectal cancer patients with a Charlson comorbidity score Ն2 were less likely to undergo any cancer-directed treatment when compared with patients with a score of 0 to 1 (multivariate OR ϭ 0.68; 95% CI, 0.45-1.03; P ϭ 0.07). But it should be noted that, after adjusting for Charlson score, age was still an important independent predictor of receiving treatment of breast or colorectal cancer (multivariate OR ϭ 0.50; 95% CI, 0.33-0.76; P Ͻ 0.001). 7 An evaluation of data obtained from a SEER-Medicare linked database regarding the use of adjuvant chemotherapy for colorectal cancer demonstrated that age was the strongest determinant of adjuvant chemotherapy use even after adjustment for confounding effects based on variation in patients' demographic and clinical characteristics and after exclusion of patients with evident comorbidities. 17 In a separate population-based evaluation of patients with colorectal cancer in the Netherlands, increasing age was highly predictive of decreasing survival in a multivariate model adjusted for comorbidities. 16 A second limitation of our study was the lack of data in the SEER registry on the use of adjuvant chemotherapy. However, the most significant effects of age on survival outcome were in patients with stage I rectal cancer, for whom adjuvant chemotherapy is not indicated. Thus, one would not expect our findings in patients with stage I rectal cancer to be affected by the addition of data regarding the use of adjuvant chemotherapy in this cohort.
Studies have demonstrated the safety of cancer-directed, stage-appropriate surgery in elderly patients with a low risk of death and morbidity after elective surgery. 18 -20 The 5-year cancer-related survival rates have been shown to be equivalent among older and younger patients when stage-appropriate cancer-directed treatment is performed. 21 Other studies have shown slightly increased but not prohibitively high in-hospital mortality rates (1.2%-10%) after radical surgery for colorectal cancer among even patients over 75 to 80 years of age. [21] [22] [23] The decreased utilization of stage-appropriate surgical treatment of rectal cancer in elderly patients demonstrated in this study parallels the decreased utilization of stage-appropriate adjuvant chemotherapy for colorectal cancer among elderly patients. Pooled data from several randomized trials of 5-fluorouracil-based chemotherapy demonstrated no significant interaction between being greater than 70 years and toxicity (with the possible exception of leukopenia) or efficacy of treatment. 24 A more recent report of pooled data from trials of 5-fluorouracil and oxaliplatin demonstrated similar findings with respect to efficacy and toxicity in patients over the age of 70 years. 25 Thus, the tendency to undertreat older patients with colorectal cancer exists for both surgical and medical therapy.
CONCLUSION
This study demonstrates an association between surgical undertreatment and subsequent understaging of rectal cancer in elderly patients that provides insight into the reasons for decreased cancer-related survival rates in elderly patients. These findings emphasize the need for studies to determine the factors that determine providers' and patients' decisions regarding the type of treatments rendered or received for rectal cancer. However, given the established safety of major abdominal surgery among the elderly, whenever possible, stage-appropriate radical surgery should be offered as the first-line therapy for elderly patients with rectal cancer.
